Biodesix Operating Income 2020-2025 | BDSX
Biodesix operating income from 2020 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Biodesix Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-34 |
| 2023 | $-41 |
| 2022 | $-51 |
| 2021 | $-41 |
| 2020 | $-23 |
| 2019 | $-27 |
|
Biodesix Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-7 |
| 2025-06-30 | $-10 |
| 2025-03-31 | $-9 |
| 2024-12-31 | $-7 |
| 2024-09-30 | $-9 |
| 2024-06-30 | $-8 |
| 2024-03-31 | $-11 |
| 2023-12-31 | $-7 |
| 2023-09-30 | $-7 |
| 2023-06-30 | $-11 |
| 2023-03-31 | $-16 |
| 2022-12-31 | $-14 |
| 2022-09-30 | $-11 |
| 2022-06-30 | $-12 |
| 2022-03-31 | $-14 |
| 2021-12-31 | $-12 |
| 2021-09-30 | $-13 |
| 2021-06-30 | $-11 |
| 2021-03-31 | $-6 |
| 2020-12-31 | $-3 |
| 2020-09-30 | $-6 |
| 2020-06-30 | $-6 |
| 2020-03-31 | $-8 |
| 2019-12-31 | |
| 2019-09-30 | $-9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.083B | $0.071B |
| Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $153.002B | 27.77 |
| HCA Healthcare (HCA) | United States | $114.483B | 17.75 |
| CVS Health (CVS) | United States | $99.460B | 11.44 |
| Elevance Health (ELV) | United States | $75.335B | 11.24 |
| Cencora (COR) | United States | $69.692B | 21.99 |
| Natera (NTRA) | United States | $28.085B | 0.00 |
| DiDi Global (DIDIY) | China | $23.132B | 21.37 |
| Labcorp Holdings (LH) | United States | $22.980B | 17.52 |
| Viatris (VTRS) | United States | $16.793B | 6.26 |
| Medpace Holdings (MEDP) | United States | $15.268B | 37.90 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.244B | 0.00 |
| Solventum (SOLV) | United States | $13.550B | 13.15 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| ICON (ICLR) | Ireland | $12.161B | 12.07 |
| CochLear (CHEOY) | Australia | $11.774B | 0.00 |
| Revvity (RVTY) | United States | $11.518B | 20.04 |
| Charles River Laboratories (CRL) | United States | $9.312B | 17.93 |
| Sonic Healthcare (SKHHY) | Australia | $7.878B | 0.00 |
| Avantor (AVTR) | United States | $7.677B | 11.73 |
| BrightSpring Health Services (BTSG) | United States | $7.156B | 42.67 |
| HealthEquity (HQY) | United States | $6.788B | 25.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.207B | 0.00 |
| PACS (PACS) | United States | $6.058B | 36.84 |
| Bausch + Lomb (BLCO) | Canada | $6.022B | 39.53 |
| Sotera Health (SHC) | United States | $5.043B | 24.32 |
| Alignment Healthcare (ALHC) | United States | $4.352B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.012B | 18.80 |
| GeneDx Holdings (WGS) | United States | $2.436B | 42.79 |
| Organon (OGN) | United States | $2.134B | 2.25 |
| Establishment Labs Holdings (ESTA) | United States | $1.999B | 0.00 |
| Progyny (PGNY) | United States | $1.892B | 37.20 |
| Pediatrix Medical (MD) | United States | $1.794B | 10.71 |
| Surgery Partners (SGRY) | United States | $1.754B | 22.60 |
| Ardent Health (ARDT) | United States | $1.280B | 4.18 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.001B | 16.36 |
| Teladoc Health (TDOC) | United States | $0.889B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.828B | 13.56 |
| Nutex Health (NUTX) | United States | $0.706B | 5.40 |
| Omada Health (OMDA) | United States | $0.675B | 0.00 |
| Embecta (EMBC) | United States | $0.643B | 3.59 |
| Sonida Senior Living (SNDA) | United States | $0.642B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.563B | 25.30 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.466B | 8.57 |
| CryoPort (CYRX) | United States | $0.437B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.409B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.352B | 5.67 |
| So-Young (SY) | China | $0.339B | 0.00 |
| Agilon Health (AGL) | United States | $0.269B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.262B | 0.00 |
| Oncology Institute (TOI) | United States | $0.257B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| LifeMD (LFMD) | United States | $0.151B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.097B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.070B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.10 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |